Showing results (231-240 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|October 6, 2018
Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/SofosbuvirPatrick R Brown, Omar Sadiq, Alexander Weick, et al.
Hepatology Communications|October 6, 2018
Reactive Ductules Are Associated With Angiogenesis and Tumor Cell Proliferation in Pediatric Liver CancerSanghoon Lee, Ping Zhou, Anita Gupta, et al.
Hepatology Communications|June 7, 2019
Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and SteatohepatitisPeng Tang, Heng Boon Low, Chin Wen Png, et al.
Hepatology Communications|June 7, 2019
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic SteatohepatitisGeorge N Ioannou, Charles S Landis, Ga-Young Jin, et al.
Hepatology Communications|June 7, 2019
The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently MislabeledVictor Navarro, Bharathi Avula, Ikhlas Khan, et al.
Hepatology Communications|June 7, 2019
Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular CarcinomaAkiko Eguchi, Hiroshi Hasegawa, Motoh Iwasa, et al.
Hepatology Communications|October 28, 2021
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 VaccinationAndrew M Moon, Gwilym J Webb, Ignacio García-Juárez, et al.
Hepatology Communications|October 26, 2021
Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA-2B Score Among US AdultsSebastian Niezen, Elliot B Tapper, Hirsh Trivedi, et al.
Hepatology Communications|October 26, 2021
Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey-Based StudyOliver Glass, Daniel Liu, Elizabeth Bechard, et al.
Hepatology Communications|March 9, 2022
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular CarcinomaFrancesca Romana Ponziani, Angela De Luca, Anna Picca, et al.
Pageof 179